Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/SITAGLIPTIN-METFORMIN

Authorized

STANDARD

SITAGLIPTIN-METFORMIN

sivem pharmaceuticals ulc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: b233ec56ebed886b
Company: sivem pharmaceuticals ulc
Type: Standard

Approval Details

Approval Id: b233ec56ebed886b
Drug Approval Canada Name: SITAGLIPTIN-METFORMIN
Product Name: SITAGLIPTIN-METFORMIN
Status: Marketed
Status Date: 2023-02-06
Original Market Date: 2023-02-06
Din: 02529157
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:20.05
Atc Original: A10BD07 METFORMIN AND SITAGLIPTIN
Atc Name: a 10 bd 07
Aig Number: 0252656001
Company Name: sivem pharmaceuticals ulc
Company Address: 4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7

Active Ingredients

METFORMIN HYDROCHLORIDE

500 MG

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)

50 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b233ec56ebed886b

Type

Standard

Back to Health Canada Approvals

SITAGLIPTIN-METFORMIN - Health Canada Drug Approval Details